NCT07315672Recruiting
Acupressure for Cough in Lung Cancer Survivors
Acupressure for Cough in Lung Cancer Survivors: A Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 11 Aug 2026
Brief summary (registry, in English)
The goal of this randomized controlled trial is to examine the effect of an acupressure intervention in alleviating cough and reducing co-occurring symptoms (dyspnea, cough, and fatigue) in patients with lung cancer. The hypotheses are: 1. Acupressure can alleviate cough in lung cancer survivors; 2. Acupressure can reduce a cough-related symptom cluster (dyspnea-cough-fatigue) experienced by lung cancer survivors; 3. Acupressure can reduce the symptom burden and improve the health-related quality of life and functional capacity of lung cancer survivors experiencing cough. Participants will: Receive acupressure for 8 weeks or receive an education booklet; Keep a diary of their acupressure practice and symptoms; Be assessed at baseline (T0), early intervention (T1), post-intervention (T2), and 8 weeks after the intervention period (T3).
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 80 (estimated)
- First submitted
- 18 Dec 2025
- Start date
- 9 Mar 2026
- Primary completion date
- Dec 2026
- Lead sponsor
- The University of Hong Kong
- Diseases
- Lung cancer
- NCT number
- NCT07315672
What you commit to
- Study type: Interventional
- Planned participants: 80
- From 9 Mar 2026 to the primary completion date, Dec 2026
- 2 sites in 2 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- have received acupressure or acupuncture within the three months preceding study enrollment;
Other illness
- have unstable chronic diseases other than LC;
- have serious illnesses or other conditions that prevent the participants from following the intervention protocols;
Other
- have a life expectancy of less than 3 months;
- Be currently participating in other research programs that may affect the outcomes under investigation.
Who the study is looking for
- be at least 18 years of age;
- have a diagnosis of LC at any stage and of any pathological type;
- have a cough symptom rating ≥3 on a 0 to 10 numeric rating scale within 7 days preceding enrollment;
- can perform acupressure independently in daily activities;
- be able to read Chinese and communicate in Cantonese or Mandarin;
- be able to provide informed consent.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Hong Kong-Shenzhen Hospital Coordinator of this site? Confirm its status | Shenzhen | China | Recruiting |
| Queen Mary Hospital Coordinator of this site? Confirm its status | Hong Kong | Hong Kong SAR China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.